“Humoral and Cellular BNT162b2 MRNA-Based Booster Vaccine-Induced Immunity in Patients With Multiple Myeloma and Persistence of Neutralising Antibodies: Results of a Prospective Single-Centre Cohort Study”. Swiss Medical Weekly, vol. 153, no. 6, June 2023, p. 40090, https://doi.org/10.57187/smw.2023.40090.